Anavex Life Sciences
AVXL
108 hedge funds and large institutions have $272M invested in Anavex Life Sciences in 2021 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 16 closing their positions.
260% more capital invested
Capital invested by funds: $75.6M → $272M (+$196M)
94% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 16
71% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 24
47% more call options, than puts
Call options by funds: $12.4M | Put options by funds: $8.46M
16% more funds holding
Funds holding: 93 → 108 (+15)
5.34% more ownership
Funds ownership: 20.89% → 26.23% (+5.3%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$20.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$9.84M |
| 3 |
BlackRock
New York
|
+$7.85M |
| 4 |
GLA
Great Lakes Advisors
Chicago,
Illinois
|
+$7.52M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PA
Perceptive Advisors
New York
|
-$4.21M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$3.62M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.21M |
| 4 |
Wells Fargo
San Francisco,
California
|
-$969K |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$941K |
AVXL Hedge Fund Activity: Q1 2021 in Review
108 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Anavex Life Sciences (AVXL) for Q1 2021, worth a combined $272M — up 260% from $75.6M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new AVXL positions and 16 closed out — a net gain of 15 holders — while 41 added to existing stakes and 24 trimmed.
The largest buyer was State Street, adding an estimated $20.5M. The largest seller was Perceptive Advisors, exiting entirely with an estimated $4.21M sold.
- 108 institutional investors held Anavex Life Sciences (AVXL) as of Q1 2021, up from 93 in Q4 2020.
- Funds reported $272M of Anavex Life Sciences stock for Q1 2021, up 260% quarter-over-quarter.
- 31 funds opened new Anavex Life Sciences positions in Q1 2021 and 16 closed out, a net change of +15 holders.
- The largest Anavex Life Sciences buyer in Q1 2021 was State Street, an estimated $20.5M added.
- The largest Anavex Life Sciences seller in Q1 2021 was Perceptive Advisors, an estimated $4.21M sold.
Based on aggregated 13F filings for Q1 2021.